Arch Venture Partners X, LLC has bought stock on 4 days since Sep 2023
10% owner at Neumora Therapeutics, Inc., and 1 other company
SEC CIK 0001769012 · Filings on SEC.gov ↗
Arch Venture Partners X, LLC's record
3 months after each buy, from the first price a copier could get.
4 buys since 2023 with 3 months of prices.
Companies
Every filing
4 filings since Sep 2023, newest first
About Arch Venture Partners X, LLC
Arch Venture Partners X, LLC is a venture capital entity affiliated with ARCH Venture Partners, a leading early-stage investment firm founded in 1986 in Chicago, Illinois, specializing in building and funding companies from breakthrough science, primarily in life sciences, biotechnology, and related deep-tech fields.(
The firm, with over $10 billion in assets under management, focuses on company creation at the seed and Series A stages, partnering with scientists from top institutions to commercialize disruptive technologies aimed at preventing, detecting, and treating diseases.( Headquartered in Chicago with offices in Seattle, San Francisco, and Dublin, ARCH has a portfolio exceeding 130 active companies and has raised significant funds, including $1.46 billion in 2022 for biotechnology investments.( As a corporate insider, Arch Venture Partners X, LLC recently traded representing 10% ownership in Neumora Therapeutics, Inc. (NMRA), reflecting its active role in healthcare therapeutics investments.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.